(Q45178401)

10 December 2017

title

Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice (English)

1 reference

10 December 2017

1 reference

Wen qing Li

1

1 reference

10 December 2017

Xu chu Hu

2

1 reference

10 December 2017

Xiaohuan Zhang

3

1 reference

10 December 2017

Yanping Ge

4

1 reference

10 December 2017

Sainan Zhao

5

1 reference

10 December 2017

Yan Hu

6

1 reference

10 December 2017

Robert B Ashman

7

1 reference

10 December 2017

language of work or name

English

0 references

publication date

7 June 2011

1 reference

10 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

10 December 2017

volume

29

1 reference

10 December 2017

issue

33

1 reference

10 December 2017

page(s)

5526-5533

1 reference

Major trends in the microbial etiology of nosocomial infection.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Current treatment strategies for disseminated candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

DNA immunization using a secreted cell wall antigen Mp1p is protective against Penicillium marneffei infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

A novel glyco-conjugate vaccine against fungal pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Contribution of phospholipomannan to the surface expression of beta-1,2-oligomannosides in Candida albicans and its presence in cell wall extracts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

An immunodominant antigen of Candida albicans shows homology to the enzyme enolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Enolase from Candida albicans--purification and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Identification of major glucan-associated cell wall proteins of Candida albicans and their role in fluconazole resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

The highly immunogenic enolase and Hsp70p are adventitious Candida albicans cell wall proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Characterization of a profilin-like protein from Schistosoma japonicum, a potential new vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Active and passive immunization against oral Candida albicans infection in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

A single-step centrifugation method for separation of granulocytes and mononuclear cells from blood using discontinuous density gradient of percoll

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Genetic analysis of innate immunity in resistance to Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Neutrophils and the adaptive immune response to Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Immunity to fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Innate versus adaptive immunity in Candida albicans infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.05.030

1 reference

release_yhqeepmbkjdwhhcn2bfzkseyaq

10 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yhqeepmbkjdwhhcn2bfzkseyaq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference